In turn, BioNTech is leveraging its Covid war chest to shop.
The German biotech - which had 13.4 billion euros in cash at the end of the third quarter of 2022 and expects 16 to 17 billion in turnover for the whole of the year - should pay 636 million to put hands on InstaDeep.
She had already been a shareholder for a year in this start-up specializing in artificial intelligence (AI).
"
The acquisition of InstaDeep allows us to integrate the ever-evolving capabilities of AI into our technologies, research, drug discovery, manufacturing and deployment processes,
" said Ugur Sahin, CEO and Co-Founder. of BioNTech, which is making its largest acquisition.
Our goal is to make BioNTech a technology company where AI is seamlessly integrated into all aspects of our work.
»
To discover
Pension reform: the answers to all your questions
The choice of InstaDeep, which has 240 employees (bioengineering, data science, etc.)
This article is for subscribers only.
You have 64% left to discover.
Cultivating your freedom is cultivating your curiosity.
Keep reading your article for €0.99 for the first month
I ENJOY IT
Already subscribed?
Login